Literature analysis of hypothyroidism in patients with triple-negative breast cancer caused by pembrolizumab

doi:10.3969/j.issn.1672-3384.2026.02.006

PDF(434 KB)

Clinical Medication Journal ›› 2026, Vol. 24 ›› Issue (2) : 35-39. DOI: 10.3969/j.issn.1672-3384.2026.02.006

Original Article

Literature analysis of hypothyroidism in patients with triple-negative breast cancer caused by pembrolizumab

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 24(2): 35-39 https://doi.org/10.3969/j.issn.1672-3384.2026.02.006

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(434 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2025-07-24	2026-02-25
Issue Date
2026-03-10

Please choose a citation manager

Content to export